The safety and efficacy of second-generation basal insulin analogues in adults with type 2 diabetes at risk of hypoglycemia and use in other special populations: a …

AYY Cheng, J Wong, N Freemantle, SH Acharya… - Diabetes therapy, 2020 - Springer
Hypoglycemia is a major barrier impeding glycemic control in persons with type 2 diabetes
mellitus and creates a substantial burden on the healthcare system. Certain populations that …

[HTML][HTML] Хроническая болезнь почек: современное состояние проблемы

ММ Батюшин - Рациональная фармакотерапия в кардиологии, 2020 - cyberleninka.ru
Хроническая болезнь почек (ХБП) характеризуется ростом распространенности,
негативным вкладом в сердечно-сосудистую и общую смертность. Глобальная …

Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular …

P Rossing, SC Bain, H Bosch-Traberg… - Cardiovascular …, 2023 - Springer
Background Semaglutide is a glucose-lowering treatment for type 2 diabetes (T2D) with
demonstrated cardiovascular benefits; semaglutide may also have kidney-protective effects …

A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in …

SR Heller, MS Geybels, A Iqbal, L Liu, L Wagner… - Diabetologia, 2022 - Springer
Aims/hypothesis Hypoglycaemia is a common side effect of insulin and some other
antihyperglycaemic agents used to treat diabetes. Severe hypoglycaemia has been …

[HTML][HTML] Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish …

M Adamczak, I Kurnatowska, B Naumnik… - International Journal of …, 2024 - mdpi.com
Both chronic kidney disease (CKD) and type 2 diabetes (T2D) are modern epidemics
worldwide and have become a severe public health problem. Chronic kidney disease …

Frequency of hypoglycemia assessed by continuous glucose monitoring in advanced CKD

Y Ushiogi, H Kanehara, T Kato - … Journal of the American Society of …, 2023 - journals.lww.com
Background Hypoglycemia represents a risk for serious morbidity. We evaluated the
prevalence and risk factors of hypoglycemia by continuous glucose monitoring (CGM) in …

The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

L Sloan, AYY Cheng, J Escalada… - Diabetes, Obesity …, 2024 - Wiley Online Library
The majority of cases of chronic kidney disease (CKD) worldwide are driven by the presence
of type 2 diabetes (T2D), resulting in an increase in CKD rates over the past few decades …

Delphi-based consensus on treatment intensification in type 2 diabetes subjects failing basal insulin supported oral treatment: focus on basal insulin+ GLP-1 receptor …

GP Fadini, O Disoteo, R Candido, P Di Bartolo… - Diabetes Therapy, 2021 - Springer
Introduction The aim of this study was to elaborate a consensus on treatment intensification
strategies in patients with type 2 diabetes failing basal insulin supported oral therapy (BOT) …

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: an exploratory analysis (DEVOTE 12)

A Amod, JB Buse, DK McGuire… - Diabetes and …, 2020 - journals.sagepub.com
Aim: To investigate risk factors associated with kidney disorders in patients with type 2
diabetes (T2D) at high cardiovascular (CV) risk. Methods: In DEVOTE, a cardiovascular …

Association between reduced kidney function and incident hypoglycaemia in people with diabetes: the Stockholm Creatinine Measurements (SCREAM) project

B Runesson, Y Xu, AR Qureshi… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aim To evaluate possible associations between estimated glomerular filtration rate (eGFR)
and hypoglycaemia in adults with diabetes. Methods We conducted an observational study …